
Mercyking Pharmaceuticals Private Limited
About Mercyking Pharmaceuticals Private Limited
Data last updated:
Mercyking Pharmaceuticals Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 14 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2015PTC261931. Its GSTIN is 27AAJCM6312M1Z5 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandramani Krishnaprasad Tiwari and Poonam Chandramani Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – G 204 M/S Eight Kool Homes S. No 8 Devad Tal – Panvel, Maharashtra, India – 410206.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.52 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹5,027 (net margin 0.3%) and EBITDA of ₹10,655 (EBITDA margin 0.5%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mercyking Pharmaceuticals Private Limited's registered office is in Panvel, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No – G 204 M/S Eight Kool Homes S. No 8 Devad Tal – Panvel, Maharashtra, India – 410206
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Mercyking Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Mercyking Pharmaceuticals are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mercyking Pharmaceuticals Private Limited, buy the company report.
Financials of Mercyking Pharmaceuticals Private Limited
FY 2025 filings availableMercyking Pharmaceuticals Private Limited reported revenue of ₹19.52 Lakh (down 22% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 22% fall in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10,655 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,027 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mercyking Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mercyking Pharmaceuticals Private Limited
Mercyking Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandramani Krishnaprasad Tiwari | Director | 14 Feb 2015 | 11 Years 9 Months | Current |
| Poonam Chandramani Tiwari | Director | 31 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Mercyking Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rashrinivas Pharmaceuticals Private Limited | ₹19.54 Lakh (FY 2024) | 35.0% | Hyderabad, Telangana, India | |||
| Mercyking Pharmaceuticals Private Limitedthis company | ₹19.52 Lakh (FY 2024) | ₹5,027 | 0.3% | -22.0% | Panvel, Maharashtra, India | |
| Biojen Pharmaceuticals Private Limited | ₹19.49 Lakh (FY 2025) | -67.0% | Delhi, India | |||
| Ivy Nelson Pharmaceuticals Private Limited | ₹19.48 Lakh (FY 2019) | -14.0% | Piplod, Gujarat, India | |||
| Bromartis Pharmaceuticals Private Limited | ₹19.45 Lakh (FY 2017) | -78.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Mercyking Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mercyking Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mercyking Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mercyking Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCM6312M1Z5 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mercyking Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mercyking Pharmaceuticals Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Jaywant Haribhau Dalvi ceased to be Director on 31 Mar 2015.
Frequently asked questions
Mercyking Pharmaceuticals is an active private limited company based in Panvel, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 14 February 2015 (11+ years old) and is registered under CIN U74999MH2015PTC261931.
Mercyking Pharmaceuticals has 2 current directors:
- Chandramani Krishnaprasad Tiwari - Director
- Poonam Chandramani Tiwari - Director
The latest financial statements of Mercyking Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mercyking Pharmaceuticals is 27AAJCM6312M1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Mercyking Pharmaceuticals is U74999MH2015PTC261931. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mercyking Pharmaceuticals was incorporated on 14 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mercyking Pharmaceuticals by revenue are Rashrinivas Pharmaceuticals Private Limited, Biojen Pharmaceuticals Private Limited, Ivy Nelson Pharmaceuticals Private Limited, Bromartis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jaywant Haribhau Dalvi ceased to be Director on 31 Mar 2015. Poonam Chandramani Tiwari was appointed as Director on 31 Mar 2015. Chandramani Krishnaprasad Tiwari was appointed as Director on 14 Feb 2015.
The registered office of Mercyking Pharmaceuticals is at Flat No – G 204 MS Eight Kool Homes S. No 8 Devad Tal – Panvel, Maharashtra, India – 410206.
Mercyking Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Mercyking Pharmaceuticals is compliant as of 12 July 2026. The company is actively filing with the Registrar of Companies.

